FDA recall,
Safecor Health Ibuprofen Oral Suspension
Ibuprofen oral suspension in syringes may be cross-contaminated with other products.
Summary by Recall Canary from the FDA notice
What happened
Safecor Health, LLC of Woburn, Massachusetts, began a recall of Ibuprofen, 150 mg per 7.5 mL, Delivers: 7.5 mL, Conc: 20 mg/mL, Oral Suspension, 12mL Oral Syringes, Berry Flavor/Alcohol Free, on August 14, 2026, because of cross contamination with other products. The recall involved 302 syringes distributed in Massachusetts only. The FDA added the recall to its Enforcement Report on August 25, 2026, and included it in the weekly enforcement report on September 2, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Affected if its lot code matches.
Ibuprofen
- Strength
- 150 mg
- Lot code
- 26281630
Recall details
- Company began the recall
- Sold in
- Company
- Safecor Health, LLCWoburn, Massachusetts
- Hazard
- Contamination
- Event ID
- 99666
- Quantity recalled
- 302 syringes
All recalls from Safecor Health, LLC
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
